Adienne - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAdienne

Adienne

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Phelinun	Melphalan	2020-11-16	2029-2036	Myeloid leukemia acute , Breast neoplasms , Ovarian neoplasms , Non-hodgkin lymphoma , Multiple myeloma , Neuroblastoma , Precursor cell lymphoblastic leukemia-lymphoma , Hematopoietic stem cell transplantation , Hodgkin disease , Rhabdomyosarcoma
Tepadina	Thiotepa	2017-01-26		Breast neoplasms , Ovarian neoplasms , Sarcoma , Lymphoma , Urinary bladder neoplasms , Hematopoietic stem cell transplantation , Adenocarcinoma , Neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

myeloid leukemia

Mycophenolic acid

autoimmune diseases

urinary bladder neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use